STEVENSON, Md., Aug. 25, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Virginia on behalf of purchasers of MAXIMUS, Inc. (NYSE:MMS) (“MAXIMUS” or the “Company”) securities during the period between October 30, 2014 through February 3, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 6, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in MAXIMUS securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that in obtaining the Health Assessment Advisory Service (“HAAS”) contract, MAXIMUS set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments and MAXIMUS was struggling to recruit, train and ramp-up new health care staff to perform the assessments.
According to the complaint, following an August 5, 2015 announcement that the Company had start-up challenges, a November 12, 2015 announcement that the HAAS contract delivered an operating loss, and a February 4, 2016 announcement that the Company was unable to meet HAAS contract assessment targets, the value of MAXIMUS shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in MAXIMUS securities purchased on or after October 30, 2014 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 



